Back to Search
Start Over
GlaxoSmithKline (LSE: GSK)
- Source :
- United Kingdom Pharmaceuticals. November 12, 2019, p59, 30 p.
- Publication Year :
- 2019
-
Abstract
- We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. GlaxoSmithKline plc was formed in 2000 as a result of [...]
- Subjects :
- United States. Food and Drug Administration
Pfizer Inc. -- Joint ventures
GlaxoSmithKline PLC -- Joint ventures
Niraparib
Rilpivirine
Health care industry -- Joint ventures
Dolutegravir
Pembrolizumab
Pharmaceutical industry -- Joint ventures
Belimumab
Drugstores
Pharmacy
Health care industry
Company joint venture
Business, international
Seretide (Medication)
Trelegy Ellipta (Medication)
Boostrix (Vaccine)
Juluca (Medication)
Zejula (Medication)
Tivicay (Medication)
Nucala (Medication)
Pediarix (Vaccine)
Benlysta (Medication)
Infanrix (Medication)
Dovato (Medication)
Advair Diskus (Medication)
Breo Ellipta (Medication)
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- United Kingdom Pharmaceuticals
- Publication Type :
- News
- Accession number :
- edsgcl.607064817